Milnacipran - CAS 92623-85-3
Catalog number:
92623-85-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
COA:
Inquire
Targets:
SSRIs
Description:
Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the USA, but it is in other countries. It inhibits the reuptake of serotonin and norepinephrine in an approximately 1:3 ratio. It is well absorbed after oral dosing and has a bioavailability of 85%. It is conjugated to the inactive glucuronide and excreted in the urine as unchanged drug and conjugate. Only traces of active metabolites are found.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Dalcipran; Ixel; Savella; Toledomin
MSDS:
Inquire
1.Antidepressants modulate glycine action in rat hippocampus.
Chang HK1, Kim KH1, Kang KW2, Kang YJ2, Kim TW3, Park HK4, Kim SE4, Kim CJ4. J Exerc Rehabil. 2015 Dec 31;11(6):311-9. doi: 10.12965/jer.150263. eCollection 2015.
Antidepressants are drugs that relieve symptoms of depressive disorders. Fluoxetine, tianeptine, and milnacipran are different types of antidepressants, and they have widely been used for relieving of depression symptoms. In the present study, the effects of fluoxetine, tianeptine, and milnacipran on the glycine-induced ion current by nystatin-perforated patch clamp and on the amplitude of field potential in the hippocampal CA1 region by multichannel extracellular recording, MED64, system, were studied. In the present results, fluoxetine, tianeptine, and milnacipran reduced glycine-induced ion current in the hippocampal CA1 neurons in nystatin-perforated patch clamp method. These drugs enhanced the amplitude of the field potential in the hippocampal CA1 region in MED64 system. These results suggest that antidepressants may increase neuronal activity by enhancing field potential through inhibition on glycine-induced ion current.
2.Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States.
Liu Y1, Qian C2, Yang M2. J Manag Care Spec Pharm. 2016 Mar;22(3):263-71. doi: 10.18553/jmcp.2016.22.3.263.
BACKGROUND: Fibromyalgia (FM) affects up to 6% of U.S. adults, resulting in a significant burden on the health care system and poor quality of life for patients. Duloxetine, pregabalin, and milnacipran are approved for management of FM; however, consensus is lacking regarding optimal therapy. Patients with FM taking approved medications often do not experience meaningful symptom relief, and many experience intolerable adverse events.
3.Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH1, Song GG2. Rheumatol Int. 2016 Mar 21. [Epub ahead of print]
The aim of this study was to assess the relative efficacy and tolerability of duloxetine, pregabalin, and milnacipran at the recommended doses in patients with fibromyalgia. Randomized controlled trials (RCTs) examining the efficacy and safety of duloxetine 60 mg, pregabalin 300 mg, pregabalin 150 mg, milnacipran 200 mg, and milnacipran 100 mg compared to placebo in patients with fibromyalgia were included in this Bayesian network meta-analysis. Nine RCTs including 5140 patients met the inclusion criteria. The proportion of patients with >30 % improvement from baseline in pain was significantly higher in the duloxetine 60 mg, pregabalin 300 mg, milnacipran 100 mg, and milnacipran 200 mg groups than in the placebo group [pairwise odds ratio (OR) 2.33, 95 % credible interval (CrI) 1.50-3.67; OR 1.68, 95 % CrI 1.25-2.28; OR 1.62, 95 % CrI 1.16-2.25; and OR 1.61; 95 % CrI 1.15-2.24, respectively]. Ranking probability based on the surface under the cumulative ranking curve (SUCRA) indicated that duloxetine 60 mg had the highest probability of being the best treatment for achieving the response level (SUCRA = 0.
4.Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.
Hashimoto T1, Sakurai D2, Oda Y2, Hasegawa T3, Kanahara N4, Sasaki T3, Komatsu H5, Takahashi J6, Oiwa T7, Sekine Y8, Watanabe H2, Iyo M9. Neuropsychiatr Dis Treat. 2015 Dec 10;11:3031-40. doi: 10.2147/NDT.S95067. eCollection 2015.
BACKGROUND: We assessed the effect of switching patients with major depressive disorder to milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and explored potential biomarkers in their blood.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related SSRIs Products


CAS 93413-69-5 Venlafaxine

Venlafaxine
(CAS: 93413-69-5)

Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norepinephrine-dopa...

CAS 1229-29-4 Doxepin Hydrochloride

Doxepin Hydrochloride
(CAS: 1229-29-4)

Highly potent H1 histamine receptor antagonist (Kd = 310 pM) and tricyclic antidepressant. Also binds to the H4 histamine receptor (pKi = 6.79).

CAS 61718-82-9 Fluvoxamine maleate

Fluvoxamine maleate
(CAS: 61718-82-9)

Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and sigma-1 receptor agonist.

CAS 175131-60-9 Levomilnacipran

Levomilnacipran
(CAS: 175131-60-9)

Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Fore...

CAS 128196-01-0 Escitalopram

Escitalopram
(CAS: 128196-01-0)

Escitalopram, the S-enantiomer of citalopram, belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Escitalopram...

CAS 79559-97-0 Sertraline HCl

Sertraline HCl
(CAS: 79559-97-0)

Sertraline HCl is a 5-HT antagonist with Ki of 13 nM.

CAS 110429-35-1 Paroxetine hydrochloride hemihydrate

Paroxetine hydrochloride hemihydrate
(CAS: 110429-35-1)

Paroxetine hydrochloride hemihydrate is a antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs).

CAS 92623-85-3 Milnacipran

Milnacipran
(CAS: 92623-85-3)

Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatmen...

CAS 219861-08-2 Escitalopram Oxalate

Escitalopram Oxalate
(CAS: 219861-08-2)

Escitalopram Oxalate also known by the brand names Lexapro and Cipralex among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) ...

CAS 125494-59-9 Sibutramine hydrochloride monohydrate

Sibutramine hydrochloride monohydrate
(CAS: 125494-59-9)

A serotonin and noradrenaline reuptake inhibitor (SNR). Decreases calorie intake and increases energy expenditure.

CAS 56296-78-7 Fluoxetine hydrochloride

Fluoxetine hydrochloride
(CAS: 56296-78-7)

Fluoxetine is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.

CAS 54739-18-3 Fluvoxamine

Fluvoxamine
(CAS: 54739-18-3)

Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. It is effective in inhibiting 5-ht uptake by blo...

CAS 93413-62-8 Desvenlafaxine

Desvenlafaxine
(CAS: 93413-62-8)

Desvenlafaxine is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor with Ki of 40.2 nM and 558.4 nM, respectively.

CAS 386750-22-7 Desvenlafaxine Succinate

Desvenlafaxine Succinate
(CAS: 386750-22-7)

Desvenlafaxine Succinate is a new serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor with Ki of 40.2 nM and 558.4 nM respective...

CAS 63302-99-8 Azaphen dihydrochloride monohydrate

Azaphen dihydrochloride monohydrate
(CAS: 63302-99-8)

Azaphen dihydrochloride monohydrate is a potent inhibitor of the reuptake of serotonin. It is a tricyclic antidepressant (TCA) approved in Russia for the treatm...

CAS 19794-93-5 Trazodone

Trazodone
(CAS: 19794-93-5)

Trazodone, a phenylpiperazine compound, acts as a serotonin uptake inhibitor with antianxiety (anxiolytic) and sleep-inducing (hypnotic) effects.

CAS 24853-80-3 Azaphen

Azaphen
(CAS: 24853-80-3)

An antidepressant having effects on the autonomic nervous system; the drug is especially effective for mild and moderate depressions and a combination of Azaphe...

CAS 99300-78-4 Venlafaxine hydrochloride

Venlafaxine hydrochloride
(CAS: 99300-78-4)

Venlafaxine hydrochloride is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norep...

CAS 101152-94-7 Milnacipran HCl

Milnacipran HCl
(CAS: 101152-94-7)

Milnacipran inhibits both norepinephrine transporter (NET) and norepinephrine transporter (SERT) with IC50 of 77 nM and 420 nM, respectively. Milnacipran at hig...

CAS 136434-34-9 Duloxetine Hydrochloride

Duloxetine Hydrochloride
(CAS: 136434-34-9)

Duloxetine Hydrochloride is a serotonin-norepinephrine reuptake inhibitor with Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anx...

Chemical Structure

CAS 92623-85-3 Milnacipran

Quick Inquiry

Verification code

Featured Items